IL-17E

IL-17E

IL-17E Overview

Molecule Name
Interleukin-25
Synonyms
IL-17E,IL-25,Interleukin-25
Drug Development Progress
Drugs in Clinical Trials1
Approved Drugs0
Highest Development StagePhase 2 Clinical
Target Synonym
IL17E,IL-25,IL-17E,Interleukin-17E,Interleukin 17E,Interleukin 25
Background
Interleukin 25 (IL25) is also known as Interleukin-17E (IL-17E), is a distinct member of the IL17 cytokine family comprised of at least six members sharing a conserved cysteine-knot structure but divergent at the N-terminus. IL-25 is secreted by type 2 helper T cells (Th2) and mast cells. IL25 can induce NF-κB activation, and stimulate the production of IL8. Both this cytokine and IL17B are ligands for the cytokine receptor IL17RB. IL-25 induces the production of other cytokines, including IL-4, IL-5 and IL-13 in multiple tissues, which stimulate the expansion of eosinophils. This cytokine is an important molecule controlling immunity of the gut and has been implicated in chronic inflammation associated with the gastrointestinal tract. IL-25 can kill some types of breast cancer cells.

IL-17E Product List

Species
  • Human(2)
  • Cynomolgus(1)
  • Mouse(1)
Tag
  • -(1)
  • Fc Tag(1)
  • His Tag(1)
  • His Tag & Avi Tag(1)
Host
  • HEK293(4)
Conjugate
  • Biotin-labeled(2)
  • Unconjugated(2)
Grade
  • RUO(4)
Low Endotoxin
  • Yes(1)
  • No(3)
MoleculeCat. No.Product NameSpeciesHostStructurePurityActivitySize&PriceAdd to Cart
IL-17E
Cynomolgus IL-17E / IL-25 Protein, Fc Tag (MALS verified)
Cynomolgus
HEK293
MALSSDS-PAGE
ELISASPR

$350.00

50ug
IL-17E
Human IL-17E / IL-25 Protein, His Tag, low Endotoxin (MALS verified)
Human
HEK293
MALSSDS-PAGE
ELISACELL BASE

$165.00

20ug
IL-17E
Avitag
IL5-H82E1
Biotinylated Human IL-17E / IL-25 Protein, His,Avitag™ (MALS verified)
Human
HEK293
MALSSDS-PAGE
ELISA

$360.00

25ug
IL-17E
Avitag
ILE-M82E3
Biotinylated Mouse IL-17E Protein, His,Avitag™
Mouse
HEK293
SDS-PAGE
ELISA

$360.00

25ug
You Have Viewed 1-4 Of 4 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
XKH-001(Xinkanghe Biomedical)XKH-001Phase 2 ClinicalBeijing Kanova Biomedical Technology Co Ltd, Zhejiang Kanova Biopharmaceutical Co Ltd
Allergic asthma; Asthma; Dermatitis, Atopic; Idiopathic Pulmonary Fibrosis; Inflammation; Pulmonary Disease, Chronic Obstructive
Details
Customer Reviews